Pharma BD Deal Intelligence
Pfizer Inc. / Hospira Inc.
2015 · Acquisition/Merger · $17.0B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
67
Largely worked — most objectives met.
Pfizer acquired Hospira for $17B, the world's largest generic injectable manufacturer.
Key facts
- Announced Feb 05, 2015
- Closed Sep 03, 2015
- Deal value $17.0B
- Deal type Acquisition/Merger
- Therapeutic area Hospital/Generic Injectables & Biosimilars
- Indications Generic Injectable Pharmaceuticals, Biosimilars
- Key assets Hospira injectables, Generic portfolio
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals